Literature DB >> 1059122

Activation of bovine factor X (Stuart factor): conversion of factor Xaalpha to factor Xabeta.

K Fujikawa, K Titani, E W Davie.   

Abstract

Bovine factor X (molecular weight 55,100) is a blood coagulation factor present in plasma in a precursor or zymogen form. It is a glycoprotein which has been isolated as a two-chain structure held together by one or more disulfide bonds. During the coagulation process, factor X is converted to a serine protease by the hydrolysis of a specific peptide bond in the amino-terminal region of the heavy chain. This cleavage occurs between Arg-51 and Ile-52, giving rise to factor Xaalpha (molecular weight 45,300) and an activation peptide (molecular weight 9500). Factor Xaalpha is then converted to factor Xabeta (molecular weight 42,600) by hydrolysis of a second specific peptide bond in the carboxyl-terminal region of the heavy chain. This cleavage occurs between Arg-290 and Gly-291, giving rise to a second glycopeptide (molecular weight 2700). Factor Xaalpha and factor Xabeta have equivalent coagulant activity, indicating that the cleavage of the second peptide bond is unrelated to the activation process.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1059122      PMCID: PMC432992          DOI: 10.1073/pnas.72.9.3359

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Bovine factor X1 (Stuart factor). Primary structure of the light chain.

Authors:  D L Enfield; L H Ericsson; K A Walsh; H Neurath; K Titani
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

Review 2.  Basic mechanisms in blood coagulation.

Authors:  E W Davie; K Fujikawa
Journal:  Annu Rev Biochem       Date:  1975       Impact factor: 23.643

3.  The mechanism of activation of factor X. Kinetic control of alternative pathways leading to the formation of activated factor X.

Authors:  J Jesty; A K Spencer; Y Nemerson
Journal:  J Biol Chem       Date:  1974-09-10       Impact factor: 5.157

4.  The mechanism of activation of bovine factor X (Stuart factor) by intrinsic and extrinsic pathways.

Authors:  K Fujikawa; M H Coan; M E Legaz; E W Davie
Journal:  Biochemistry       Date:  1974-12-17       Impact factor: 3.162

5.  Comparisons of the molecular forms of activated bovine factor X. Products of activation with Russell's viper venom, insoluble trypsin, sodium citrate, tissue factor, and the intrinsic system.

Authors:  R D Radcliffe; P G Barton
Journal:  J Biol Chem       Date:  1973-10-10       Impact factor: 5.157

6.  Purification of Factor VII from bovine plasma. Reaction with tissue factor and activation of Factor X.

Authors:  J Jesty; Y Nemerson
Journal:  J Biol Chem       Date:  1974-01-25       Impact factor: 5.157

7.  The purification and properties of activated factor X. Bovine factor X activated with Russell's viper venom.

Authors:  R D Radcliffe; P G Barton
Journal:  J Biol Chem       Date:  1972-12-10       Impact factor: 5.157

8.  The chromatographic determination of cystine and cysteine residues in proteins as s-beta-(4-pyridylethyl)cysteine.

Authors:  M Friedman; L H Krull; J F Cavins
Journal:  J Biol Chem       Date:  1970-08-10       Impact factor: 5.157

9.  Bovine factors X 1 and X 2 (Stuart factor). Isolation and characterization.

Authors:  K Fujikawa; M E Legaz; E W Davie
Journal:  Biochemistry       Date:  1972-12-19       Impact factor: 3.162

10.  The preparation of activated factor X and its action on prothrombin.

Authors:  J Jesty; M P Esnouf
Journal:  Biochem J       Date:  1973-04       Impact factor: 3.857

View more
  11 in total

1.  The Journey of Protein S from an Anticoagulant to a Signaling Molecule.

Authors:  V S Pilli; William Plautz; Rinku Majumder
Journal:  JSM Biochem Mol Biol       Date:  2016-08-08

2.  Thrombolysis by chemically modified coagulation factor Xa.

Authors:  E L G Pryzdial; S C Meixner; K Talbot; L J Eltringham-Smith; J R Baylis; F M H Lee; C J Kastrup; W P Sheffield
Journal:  J Thromb Haemost       Date:  2016-08-17       Impact factor: 5.824

3.  High Serum Stability of Collagen Hybridizing Peptides and Their Fluorophore Conjugates.

Authors:  Lucas L Bennink; Daniel J Smith; Catherine A Foss; Martin G Pomper; Yang Li; S Michael Yu
Journal:  Mol Pharm       Date:  2017-05-08       Impact factor: 4.939

4.  Group D prothrombin activators from snake venom are structural homologues of mammalian blood coagulation factor Xa.

Authors:  Veena S Rao; Jeremiah S Joseph; R Manjunatha Kini
Journal:  Biochem J       Date:  2003-02-01       Impact factor: 3.857

5.  Characterization of an almost full-length cDNA coding for human blood coagulation factor X.

Authors:  M R Fung; C W Hay; R T MacGillivray
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

6.  Factor Xa binding to annexin 2 mediates signal transduction via protease-activated receptor 1.

Authors:  Gourab Bhattacharjee; Jasimuddin Ahamed; Rafal Pawlinski; Cheng Liu; Nigel Mackman; Wolfram Ruf; Thomas S Edgington
Journal:  Circ Res       Date:  2008-01-03       Impact factor: 17.367

7.  Human plasma protein C: isolation, characterization, and mechanism of activation by alpha-thrombin.

Authors:  W Kisiel
Journal:  J Clin Invest       Date:  1979-09       Impact factor: 14.808

8.  Mass Spectrometry Reveals a Multifaceted Role of Glycosaminoglycan Chains in Factor Xa Inactivation by Antithrombin.

Authors:  Burcu B Minsky; Rinat R Abzalimov; Chendi Niu; Yunlong Zhao; Zachary Kirsch; Paul L Dubin; Sergey N Savinov; Igor A Kaltashov
Journal:  Biochemistry       Date:  2018-07-25       Impact factor: 3.162

9.  Pathways in the activation of human coagulation factor X.

Authors:  K Mertens; R M Bertina
Journal:  Biochem J       Date:  1980-03-01       Impact factor: 3.857

10.  How to find simple and accurate rules for viral protease cleavage specificities.

Authors:  Thorsteinn Rögnvaldsson; Terence A Etchells; Liwen You; Daniel Garwicz; Ian Jarman; Paulo J G Lisboa
Journal:  BMC Bioinformatics       Date:  2009-05-16       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.